Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Dice Therapeutics rallies as it agrees to be bought by Lilly
07:01am, Tuesday, 20'th Jun 2023
Dice Therapeutics Inc. DICE stock is up by 40% in premarket trades Tuesday after it agreed to be purchased by Eli Lilly & Co. LLY for $48 a share in a deal that values the immunology company at about
Eli Lilly to buy Dice Therapeutics in $2.4 billion deal
07:00am, Tuesday, 20'th Jun 2023
Eli Lilly and Co will buy Dice Therapeutics Inc in an all-cash deal worth about $2.4 billion to boost its autoimmune drug portfolio, the companies said on Tuesday.
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
03:23am, Tuesday, 20'th Jun 2023
The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to keep up with demand.
Lilly's (LLY) Migraine Drug Fails Vis-a-Vis Pfizer's Nurtec ODT
12:29pm, Monday, 19'th Jun 2023
Results from a post-approval study show that treatment with Lilly's (LLY) Emgality failed to achieve statistical superiority over Pfizer's Nurtec ODT in preventing episodic migraine in adults.
Eli Lilly's migraine drug fails to meet main goal in post-approval study
12:28pm, Friday, 16'th Jun 2023
Eli Lilly said on Friday its drug Emgality did not meet the primary goal of superiority to Pfizer Inc's Nurtec ODT in prevention of episodic migraine in a post-approval study.
3 Top Stocks to Buy and Hold for the Next Decade
10:15am, Friday, 16'th Jun 2023
Brookfield boasts high-quality assets spanning wind, solar, hydroelectric, and other sustainable projects. Eli Lilly is staking out dominant positions in three huge areas: diabetes, obesity, and Alzhe
The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry
03:36pm, Thursday, 15'th Jun 2023
Biotech and pharma companies are evaluating how AI could make their businesses better. The CEO of Eli Lilly said he expects AI to massively change the productivity of the workplace.
Five things to know about berberine, the supplement being compared to the weight-loss drug Ozempic
03:32pm, Thursday, 15'th Jun 2023
By now, most Americans have heard of Ozempic, Mounjaro and Wegovy, the Type 2 diabetes drugs that are also helping people lose weight — in some cases, significant amounts.
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
02:13pm, Thursday, 15'th Jun 2023
Eli Lilly inked a gene-editing collaboration with Verve Therapeutics that gave the young biotech "pharma validation."
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:02am, Thursday, 15'th Jun 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
2 Market-Beating Stocks With More Upside Potential
08:45am, Thursday, 15'th Jun 2023
Eli Lilly and Novo Nordisk are among the leaders in diabetes and obesity care. Both companies will continue to makes important strides in these two areas.
Eli Lilly CEO says Medicare price negotiations could harm drug development
03:51pm, Tuesday, 13'th Jun 2023
Ricks said the "biggest problem" with the IRA provision stems from a difference in timeline for negotiating prices on two different types of drugs.
Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David Ricks
02:34pm, Tuesday, 13'th Jun 2023
Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement
Eli Lilly and Company (LLY) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)
07:02pm, Monday, 12'th Jun 2023
Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023 4:20 PM ET Company Participants Anat Ashkenazi - Chief Financial Officer Conference Call Particip
2 Biotech Stocks That Could Help Make You a Fortune
07:30am, Monday, 12'th Jun 2023
CRISPR Therapeutics' fortunes may soon change for the better. Eli Lily with its strong pipeline has a favorable outlook ahead.
